金花股份致力于推动骨骼肌肉领域学科发展,持续开展上市后临床研究,潜心夯实循证证据,助力提升临床诊疗。近日,一项《The Efficacy and Safety of Bionic Tiger Bone Powder for the Treatment of Knee Osteoarthritis in Early Stage: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial》研究成果发布于《ORIGINAL RESEARCH》杂志,研究权威性高、影响因子大。为金天格治疗KOA又添力证。